Department of Plant Biochemistry (ZMBP), Eberhard-Karls-University, 72076 Tübingen, Germany.
State Key Laboratory of Crop Stress Biology in Arid Areas, College of Horticulture, Northwest A&F University, Yangling, Shaanxi 712100, China.
Plant Cell. 2017 Sep;29(9):2285-2303. doi: 10.1105/tpc.17.00376. Epub 2017 Aug 25.
BAK1 is a coreceptor and positive regulator of multiple ligand binding leucine-rich repeat receptor kinases (LRR-RKs) and is involved in brassinosteroid (BR)-dependent growth and development, innate immunity, and cell death control. The BAK1-interacting LRR-RKs BIR2 and BIR3 were previously identified by proteomics analyses of in vivo BAK1 complexes. Here, we show that BAK1-related pathways such as innate immunity and cell death control are affected by BIR3 in BIR3 also has a strong negative impact on BR signaling. BIR3 directly interacts with the BR receptor BRI1 and other ligand binding receptors and negatively regulates BR signaling by competitive inhibition of BRI1. BIR3 is released from BAK1 and BRI1 after ligand exposure and directly affects the formation of BAK1 complexes with BRI1 or FLAGELLIN SENSING2. Double mutants of and show spontaneous cell death and constitutive activation of defense responses. BAK1 and its closest homolog BKK1 interact with and are stabilized by BIR3, suggesting that double mutants mimic the spontaneous cell death phenotype observed in mutants via destabilization of BIR3 target proteins. Our results provide evidence for a negative regulatory mechanism for BAK1 receptor complexes in which BIR3 interacts with BAK1 and inhibits ligand binding receptors to prevent BAK1 receptor complex formation.
BAK1 是多种配体结合类富亮氨酸重复受体激酶(LRR-RKs)的辅助受体和正调控因子,参与油菜素内酯(BR)依赖的生长发育、先天免疫和细胞死亡调控。先前通过体内 BAK1 复合物的蛋白质组学分析鉴定了与 BAK1 相互作用的 LRR-RKs BIR2 和 BIR3。在这里,我们表明,先天免疫和细胞死亡调控等 BAK1 相关途径受 BIR3 的影响,BIR3 还强烈抑制 BR 信号。BIR3 直接与 BR 受体 BRI1 和其他配体结合受体相互作用,并通过竞争性抑制 BRI1 来负调控 BR 信号。BIR3 在配体暴露后从 BAK1 和 BRI1 释放,并直接影响 BAK1 与 BRI1 或鞭毛蛋白感受 2 形成复合物。和的双突变体表现出自发细胞死亡和防御反应的组成型激活。BAK1 和其最接近的同源物 BKK1 与 BIR3 相互作用并被其稳定,表明双突变体通过破坏 BIR3 靶蛋白,模拟了在突变体中观察到的自发细胞死亡表型。我们的结果为 BAK1 受体复合物的负调控机制提供了证据,其中 BIR3 与 BAK1 相互作用并抑制配体结合受体,以防止 BAK1 受体复合物形成。